Navigation Links
Aerovance Secures $20 Million in Debt Financing
Date:3/28/2008

BERKELEY, Calif., March 28 /PRNewswire/ -- Aerovance Inc. today announced it has secured $20 million in venture debt financing. Oxford Finance Corporation led the syndicate, which includes Silicon Valley Bank and Comerica Bank. Aerovance drew down $10 million from the financing line at closing. The remaining $10 million is available upon the achievement of corporate milestones.

"This financing reflects continued interest and enthusiasm in Aerovance and our clinical programs," said Mark Perry, Aerovance's president and chief executive officer. "With this additional capital, we will continue to pursue our strategic goals, including a global partnership for our lead program, Aerovant(TM), and to build value in the company through development of our respiratory and inflammatory disease candidates."

Aerovant(TM) is a recombinant human IL-4 variant that is a potent inhibitor of both the IL-4 and IL-13 receptors. Aerovance acquired the worldwide rights to the drug candidate when the company was formed as a spin-out of Bayer Pharmaceuticals Corporation in 2004.

Aerovance Inc. is a Berkeley, Calif.-based biopharmaceutical company focused on the development and commercialization of breakthrough therapies for the treatment of respiratory and inflammatory diseases. For more information, visit http://www.aerovance.com.


'/>"/>
SOURCE Aerovance Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. Amarin Secures Global Intellectual Property Rights for Lipid Programs
2. Ranier Technology Secures GBP8m Funding for its Cadisc Replacement Spinal Discs
3. Halogen Announces Record Year - Company Solidifies Leadership Position, Secures Strategic Wins Over Competition
4. Taligen Therapeutics Secures Series B Financing
5. Neptune Technologies & Bioressources Inc. Secures Access to Nationwide Consumer Mass Market in the United States
6. Dendreon Secures $130 Million Committed Equity Financing Facility
7. Apollo Endosurgery, Inc. Secures $11.5 Million in Series A Financing.
8. Altheus Therapeutics Secures $3.6 Million in Venture Capital
9. Weil Gotshal Wins Major Victory for Applera; Secures Summary Judgment Invalidating Three Patents
10. Hyperion Therapeutics Secures $40 Million In Series B Round
11. Microchip Biotechnologies, Inc. Secures Exclusive License to Use New University of Alberta Technology for Developing Microfluidic Devices
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... Apellis Pharmaceuticals, Inc. today announced positive ... its complement C3 inhibitor, APL-2. The trials were ... studies designed to assess the safety, tolerability, pharmacokinetics ... healthy adult volunteers. Forty subjects were ... dose (ranging from 45 to 1,440mg) or repeated ...
(Date:6/23/2016)... 23, 2016 On Wednesday, June 22, ... down 0.22%; the Dow Jones Industrial Average edged 0.27% lower ... 2,085.45, down 0.17%. Stock-Callers.com has initiated coverage on the following ... Therapeutics (NASDAQ: NKTR ), Aralez Pharmaceuticals Inc. (NASDAQ: ... BIND ). Learn more about these stocks by accessing ...
(Date:6/23/2016)... (PRWEB) , ... June 23, 2016 , ... ... a new line of intelligent tools designed, tuned and optimized exclusively for Okuma ... 12–17 in Chicago. The result of a collaboration among several companies with expertise ...
(Date:6/22/2016)... DIEGO , June 22, 2016 ... that will allow them to produce up to ... from one lot within one week. These high-quality, ... time laboriously preparing cells and spend more time ... possible through a proprietary, high-volume manufacturing process that ...
Breaking Biology Technology:
(Date:5/3/2016)... May 3, 2016  Neurotechnology, a provider of ... MegaMatcher Automated Biometric Identification System (ABIS) , a ... projects. MegaMatcher ABIS can process multiple complex biometric ... combination of fingerprint, face or iris biometrics. It ... and MegaMatcher Accelerator , which have ...
(Date:4/26/2016)... 2016 Research and Markets has ... Market 2016-2020"  report to their offering.  , ,     ... The analysts forecast the global multimodal biometrics market ... the period 2016-2020.  Multimodal biometrics is ... as the healthcare, BFSI, transportation, automotive, and government ...
(Date:4/14/2016)... Israel , April 14, 2016 ... Authentication and Malware Detection, today announced the appointment of ... assumed the new role. Goldwerger,s leadership appointment ... on the heels of the deployment of its platform ... BioCatch,s behavioral biometric technology, which discerns unique cognitive and ...
Breaking Biology News(10 mins):